Santen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SANTEN, and what generic and branded alternatives to SANTEN drugs are available?
SANTEN has three approved drugs.
Drugs and US Patents for Santen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Santen | QUIXIN | levofloxacin | SOLUTION/DROPS;OPHTHALMIC | 021199-001 | Aug 18, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Santen | ALAMAST | pemirolast potassium | SOLUTION/DROPS;OPHTHALMIC | 021079-001 | Sep 24, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Santen | IQUIX | levofloxacin | SOLUTION/DROPS;OPHTHALMIC | 021571-001 | Mar 1, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Santen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Santen | QUIXIN | levofloxacin | SOLUTION/DROPS;OPHTHALMIC | 021199-001 | Aug 18, 2000 | 5,053,407 | ⤷ Try a Trial |
Santen | QUIXIN | levofloxacin | SOLUTION/DROPS;OPHTHALMIC | 021199-001 | Aug 18, 2000 | 4,382,892 | ⤷ Try a Trial |
Santen | ALAMAST | pemirolast potassium | SOLUTION/DROPS;OPHTHALMIC | 021079-001 | Sep 24, 1999 | 5,034,230*PED | ⤷ Try a Trial |
Santen | QUIXIN | levofloxacin | SOLUTION/DROPS;OPHTHALMIC | 021199-001 | Aug 18, 2000 | 4,551,456 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.